Notabene Raises $10.2M Series A!
We are proud to have been there from the start and are happy to continue backing their outstanding team through our follow-on investment in this Series A.
BTP: Simplifying the Deployment and Management of Enterprise Blockchain Infrastructure
We are excited to back BTP’s enterprise blockchain experts on their mission to bring the benefits of distributed ledgers to businesses.
Unchained Capital Raises $25M Series A
Our portfolio company Unchained has closed a $25M Series A, bringing its company valuation to $125M.
Celestia: The General-Purpose Data Availability Layer of the Decentralized Internet
Read our Investment Thesis on why Celestia and its general-purpose data availability layer is a paradigm shift for scalable Blockchain architecture and a catalyst towards a decentralized Internet.Read
Celestia Closes $1.5M Seed Round
We are thrilled to be a major part of the $1.5M seed round of Celestia alongside Binance Labs, Maven11 and KR1.Read
Unchained Capital Raises $5.5M Seed Round
Unchained Capital raised a $5.5 million equity seed round led by institutional Bitcoin technology and financial services firm NYDIG.Read
Unchained Capital: Unlocking the Potential of Bitcoin-Native Multisignature Capabilities
Unchained Capital provides financial services on top of its highly secure and innovative collaborative custody infrastructure tailored to the needs of long-term Bitcoin holders.Read
Notabene Raises Seed Round of $1.77M
As Notabene's first institutional investor in their pre-Seed stage, we are happy to be accompanied by well-known names from the Blockchain and FinTech space: our network partners at Castle Island Ventures led the Seed round, joined by Green Visor Capital, among others.Read
Notabene: Embracing Regulation within the Blockchain Space
Notabene is building a Blockchain-focused compliance platform to provide crypto businesses with the tools to implement regulatory compliance in a simple way. Their diverse founder team follows a Blockchain-first approach combining decentralized-identity technology with the highest compliance standards.Read
Molecule: The Next Stage in the Evolution of Drug Development
Molecule aims to disrupt the pharmaceutical drug discovery and development industry. Their outstanding team is building a trust-less open platform for the efficient management of pharmaceutical intellectual property (IP) between researchers and investors.Read